Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Hedge Fund Titan Rokos Said to Quit UK for Greece
Business & Finance

Hedge Fund Titan Rokos Said to Quit UK for Greece

Bloomberg Markets Tuesday 08 September 2026, 09:25 UTC 1 min read
Key Points

Chris Rokos, the founder of Rokos Capital Management, is set to leave the UK and switch his residency to Greece, people with knowledge of the arrangement said. Rokos will also open an office in Athens as part of the move, one of the people said. He is the latest in a string of high-profile financiers and business leaders that have chosen to leave after the abolition of the UK's long-standing non-dom regime and increased taxes on everything from private equity investments to inheritances and...

Chris Rokos, the founder of Rokos Capital Management, is set to leave the UK and switch his residency to Greece, people with knowledge of the arrangement said. Rokos will also open an office in Athens as part of the move, one of the people said. He is the latest in a string of high-profile financiers and business leaders that have chosen to leave after the abolition of the UK's long-standing non-dom regime and increased taxes on everything from private equity investments to inheritances and capital gains. Bloomberg's Jack Sidders reports. (Source: Bloomberg)
Rokos Said (PERSON) UK (LOCATION) Greece (LOCATION) Chris Rokos (PERSON) Rokos Capital Management (ORG) Rokos (ORG) Athens (LOCATION) Bloomberg (ORG) Jack Sidders (PERSON)
Originally published by Bloomberg Markets Read original →

Related Stories

Investors pour record US$1.3 trillion into Hong Kong investment products

Sales of non-exchange-traded investment products in Hong Kong surged to a record HK$9.9 trillion (US$1.3 trillion) in 2025, marking a 63 per cent year-on-year increase, according to the latest joint survey by the Securities and Futures Commission (SFC) and the Hong Kong Monetary Authority (HKMA). A significant expansion in market participation drove the record-breaking performance. The number of investors completing at least one transaction rose 33 per cent to a record at more than 1.6...

South China Morning Post 7m ago

Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback

Novartis saw a treatment for a rare muscle-wasting disease fail a late-stage study, the third clinical-trial setback in a week. The medicine was the centerpiece of Novartis’s $12 billion takeover of Avidity Biosciences and raises questions about the drugmaker’s growth prospects. Fabienne Kinzelmann reports on Bloomberg Television.

Bloomberg Markets 12m ago

Six months into Hormuz blockade, Qatar and UAE test ways to keep LNG moving

LNG exporters are looking for ways around the disruption in Hormuz, with three Gulf cargoes recently moved using ship-to-ship transfers (STS) as Qatar and UAE exports remain far below pre-war levels. Qatar and the UAE are rerouting damaged LNG tankers via ship-to-ship transfers to keep gas flowing to buyers worldwide, in emergency operations that add more than $1 million per transfer and up to 35 hours of additional sailing time as the ongoing war continues to affect traffic through the...

Euronews 15m ago

Cowan: South Africa Has Yet to Turn Growth Corner

David Cowan, Africa Economist at Citi Research, says South Africa has yet to turn the corner on growth, with the economy showing resilience rather than a strong acceleration. He also says Zimbabwe’s recovery is benefiting from improved fiscal discipline, higher gold and lithium prices and stronger agricultural exports. Cowan discusses the challenges of de-dollarization, signs of renewed foreign investor interest and the importance of Zimbabwe getting its lithium policy right with Abeer Abu...

Bloomberg Markets 16m ago